Both ICIs were applied as monotherapy to tumor-free Msh2loxP/loxP; TgTg(Vil1-cre mice and overall survival was analyzed along with a longitudinal assessment of immunologic changes in the periphery and bone marrow. Here, VIL1 is linked to neoplasm.